Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: Gary Strike who wrote (819)	5/6/1998 8:19:00 PM
From: PK	Read Replies (2) \| Respond to of 2135

I Think you might see a jump of couple points tomorrow... It might dip to upper 20's during the day but will close higher than today's close... Good luck to all....

To: Gary Strike who wrote (819)	5/6/1998 11:41:00 PM
From: Philip H. Lee	Respond to of 2135

EntreMed Says Cancer Drug at Least 5 Years Off: Forum (Update1) Bloomberg News May 6, 1998, 2:36 p.m. PT Excerpt: ----- EntreMed Inc. could take more than five years to bring its experimental cancer drug to market, even working at top speed, the company's chairman said. ''The fastest those things have ever occurred from concept to clinic is just under seven years,'' John Holaday, chairman, chief executive officer and co-founder of EntreMed, told the Bloomberg Forum. ''We would like to beat that fastest-ever development time,'' Holaday said. ''I would like to make that as a promise. . . unfortunately I can't.'' ----- news.com Philip